No CrossRef data available.
Article contents
Doit-on limiter les contacts entre les résidents et les représentants de compagnies pharmaceutiques?
Published online by Cambridge University Press: 21 May 2015
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Club de Lecture JCMU • CJEM Journal Club
- Information
- Copyright
- Copyright © Canadian Association of Emergency Physicians 2002
References
1.Ziegler, MG, Lew, P, Singer, BC.The accuracy of drug information from pharmaceutical sales representatives. JAMA 1995; 273:1296–8.CrossRefGoogle ScholarPubMed
2.Wazana, A.Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 2000;283:373–80.CrossRefGoogle ScholarPubMed
3.Orlowski, JP, Wateska, L.The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch. Chest 1992;102(1):270–3.CrossRefGoogle ScholarPubMed
4.Chren, MM, Landefeld, CS.Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994;271(9):684–9.CrossRefGoogle ScholarPubMed
5.Steinman, MA, Shlipak, MG, McPhee, SJ.Of principles and pens: attitudes and practices of medecine housestaff toward pharmaceutical industry promotions. Am J Med 2001;110(7):551–7.CrossRefGoogle Scholar
You have
Access